What Is Health Effects of Space Travel on Human Physiology? Exploring the Universe

Image: NASA

When astronaut Scott Kelly returned from his year-long mission aboard the International Space Station in 2016, his body had fundamentally changed. His bones had weakened, his muscles had atrophied despite rigorous daily exercise, and his vision had altered in ways that surprised even the space medicine experts monitoring him. Yet perhaps most startling was what researchers discovered afterward: some of these changes persisted for months, and a few may never fully reverse. These observations raise an unsettling question that will only grow more urgent as humanity plans longer missions to the Moon and Mars: what does space do to us?

The health effects of space travel represent one of the most pressing challenges facing human spaceflight. As private companies and national space agencies push toward establishing permanent lunar bases and mounting crewed missions to Mars—journeys that could last two to three years—understanding how the space environment damages human physiology has moved from academic curiosity to existential necessity. The stakes could not be higher: without solving the puzzle of space-induced health degradation, we risk sending astronauts on missions from which they may never fully recover.

What Is Health Effects of Space Travel on Human Physiology?

The health effects of space travel encompass a constellation of physiological changes that occur when humans venture beyond Earth’s protective envelope. These effects arise primarily from two environmental factors: microgravity—the near-weightless condition created when an orbiting spacecraft and its occupants fall toward Earth at the same rate—and increased radiation exposure from cosmic rays and solar particles unfiltered by Earth’s magnetic field and atmosphere. Unlike terrestrial illnesses, these are not pathogenic; they result from the body’s adaptation to an environment radically different from the one in which human physiology evolved over millions of years. The spectrum of effects ranges from temporary discomforts like space sickness and fluid shifts in the face, to more serious long-term concerns including bone density loss, muscle atrophy, cardiovascular deconditioning, and increased cancer risk from radiation exposure.

The systematic study of space medicine began in earnest during the 1960s Space Race, when both American and Soviet programs recognized that simply reaching space was insufficient—astronauts and cosmonauts needed to survive and function there. Early observations from Mercury, Gemini, and Apollo missions revealed that the space environment was decidedly hostile to human physiology. The Russians, who accumulated more spaceflight experience through their Salyut space stations, documented many of the chronic effects of microgravity exposure. American research accelerated dramatically with the Space Shuttle program and the construction of the International Space Station, which enabled researchers to monitor astronauts during extended missions and study adaptation mechanisms in real time. This cumulative knowledge, drawn from over sixty years of human spaceflight and thousands of person-days in orbit, forms the foundation of our current understanding.

What We Know So Far

The human body evolved under constant gravitational acceleration of approximately 9.8 meters per second squared—a force so fundamental to our existence that it shaped every system from our skeletal structure to our vestibular system. In microgravity, this constant stimulus vanishes, triggering a cascade of physiological adaptations that are simultaneously remarkable and harmful. Within hours of entering orbit, fluid begins shifting from the lower body toward the head, creating the characteristic “puffy face” and sinus congestion that plague space travelers. Over days and weeks, the body initiates more dramatic changes: bones begin losing mineral content at rates far exceeding normal aging—astronauts can lose one to two percent of bone density monthly, concentrated in weight-bearing areas like the pelvis, femur, and lumbar spine. Simultaneously, muscles atrophy rapidly, particularly those responsible for posture and weight-bearing, shrinking by up to twenty percent during prolonged missions despite astronauts exercising two to three hours daily.

Consider the experience of an astronaut’s cardiovascular system like a riverboat captain navigating a suddenly flat landscape. On Earth, gravity constantly pulls blood toward the legs, requiring the heart and blood vessels to work against this force to maintain circulation. In microgravity, this gravitational gradient disappears. The cardiovascular system, responding to signals that blood volume is excessive in the upper body, begins reducing overall blood plasma volume by ten to twenty percent. The heart muscle itself, no longer fighting gravity, becomes weaker and smaller. When these astronauts return to Earth and gravity reasserts itself, their cardiovascular systems are unprepared—blood pools in the legs, blood pressure drops, and some astronauts experience orthostatic intolerance, where standing up briefly causes dizziness, visual blackout, or syncope. Recovery can take weeks to months.

The Future of Exploration

Understanding these mechanisms has shifted from theoretical interest to practical urgency as space agencies commit to ambitious exploration timelines. NASA’s Artemis program aims to return humans to the Moon by the mid-2020s, with plans for sustained lunar bases by the end of the decade. Meanwhile, SpaceX and other commercial entities are developing capabilities for extended Mars missions, which could involve six to nine months of transit through deep space, plus up to 18 months on the Martian surface. These timelines exceed the duration of current International Space Station expeditions, meaning astronauts will face cumulative exposure to microgravity’s effects beyond what we’ve thoroughly studied. The challenge compounds when considering that the radiation environment of deep space—unshielded by Earth’s magnetosphere—adds a completely different physiological stressor to the microgravity effects already well documented in Earth orbit.

Current countermeasures, while valuable, are far from perfect solutions. Astronauts aboard the ISS perform resistive exercise with specialized equipment like the Advanced Resistive Exercise Device (ARED), combined with cardiovascular training on a treadmill and cycle ergometer. Pharmaceutical interventions such as bisphosphonates have shown modest promise in slowing bone loss. External pressure suits and lower-body negative pressure devices provide temporary relief by mechanically restoring gravitational gradients. Yet even with these measures, long-duration spaceflight leaves persistent deficits—bone density may take years to recover post-flight, some muscle groups never fully regain pre-flight strength, and vision problems remain partially unexplained and difficult to reverse.

Recent Breakthroughs in Health Effects of Space Travel on Human Physiology

Recent years have brought significant advances in understanding why space travel damages human health, moving beyond simple descriptions of what happens toward mechanistic explanations of how it happens. A landmark 2021 study published in Nature Communications revealed that microgravity triggers profound changes in the expression of thousands of genes, particularly those involved in immune function, suggesting that astronauts may have suppressed immunity to infections—a critical concern for long-duration missions. Simultaneously, research using advanced imaging on the ISS has clarified that the vision problems experienced by some long-duration spaceflight participants, termed Visual Impairment, Intracranial Pressure syndrome (VIIP), may involve a combination of intracranial pressure elevation, optic disc swelling, and choroidal folds, though the precise mechanisms remain incompletely understood. Most intriguingly, 2023 and 2024 studies have identified epigenetic changes—alterations in how genes are expressed without changes to DNA sequence itself—that persist even after astronauts return to Earth, suggesting that spaceflight may have long-term molecular consequences we’re only beginning to appreciate.

Current research priorities reflect the needs of future exploration. NASA and international space agencies are now conducting comprehensive studies of astronauts before, during, and after spaceflight, collecting data on bone density, muscle physiology, cardiovascular function, immune markers, and genetic expression. The commercial space industry, including companies like Axiom Space and Virgin Galactic, is generating opportunities for more diverse populations to experience spaceflight, providing researchers with larger datasets and revealing whether health effects vary based on age, sex, fitness level, or genetic background. A crucial open question remains: can we identify astronauts more susceptible to severe deconditioning, and can we develop interventions tailored to individual physiology rather than applying uniform countermeasures to all spacefarers?

Why Health Effects of Space Travel on Human Physiology Matters for the Future

The implications of space medicine extend far beyond astronauts and cosmic exploration. Understanding how the body adapts to microgravity has illuminated fundamental principles of human physiology applicable to patients on Earth. Research on bone loss in astronauts has contributed to our understanding of osteoporosis, while studies of muscle atrophy in space have informed treatment strategies for sarcopenia in elderly populations and patients with prolonged immobilization. The vestibular research conducted in space has clarified how the inner ear senses gravity and motion, with applications for treating vertigo and balance disorders. Perhaps most significantly, space medicine has become a proving ground for understanding how humans can adapt to extreme environments—knowledge increasingly relevant as climate change, pandemics, and potential future crises may force humanity into confined spaces or isolated environments resembling the ISS.

Yet formidable challenges remain before we can confidently send humans on multi-year deep space missions. The radiation environment beyond Earth’s magnetosphere poses risks—including elevated cancer rates, central nervous system damage, and cataracts—that we still struggle to mitigate. The combined effects of radiation and microgravity, which may interact synergistically to damage tissue, remain incompletely characterized. Long-term psychological effects of isolation during deep space missions add another dimension to crew health that requires dedicated investigation. Perhaps most troublingly, some space-induced changes, particularly those affecting bone density and vision, show incomplete recovery even years after spaceflight, raising the question of whether some astronauts may experience permanent health consequences from exploration missions.

Key Takeaways

• Microgravity causes rapid bone loss—up to two percent monthly in weight-bearing bones—and profound muscle atrophy despite regular exercise, representing the most significant long-term threat to astronaut health during extended space missions.
• The body’s cardiovascular system adapts to weightlessness by reducing blood volume and cardiac muscle mass, causing dangerous orthostatic intolerance upon return to Earth where gravity reasserts its effects on circulation.
• Radiation exposure in deep space, combined with immune suppression triggered by microgravity, poses elevated cancer risk and other long-term health consequences that current countermeasures only partially address.
• Recent genomic and epigenetic studies reveal that spaceflight triggers extensive changes in gene expression affecting immune function, bone metabolism, and other physiological systems, with some changes persisting after astronauts return to Earth.
• Solving the puzzle of space-induced health degradation is essential for realizing humanity’s ambitions for lunar bases and Mars missions, making space medicine research critical infrastructure for the future of human exploration.